Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-2-17
pubmed:abstractText
Spinocerebellar ataxia type 17 (SCA17) is an autosomal dominant cerebellar ataxia caused by expansion of CAG/CAA trinucleotide repeats in the TATA-binding protein (TBP) gene. Because the number of triplets in patients with SCA17 in previous studies ranged from 43 to 63, the normal number of trinucleotide units has been considered to be 42 or less. However, some healthy subjects in SCA17 pedigrees carry alleles with the same number of expanded repeats as patients with SCA17.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0003-9942
pubmed:author
pubmed:issnType
Print
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
209-12
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14967767-Adult, pubmed-meshheading:14967767-Alleles, pubmed-meshheading:14967767-Alzheimer Disease, pubmed-meshheading:14967767-DNA, pubmed-meshheading:14967767-DNA Primers, pubmed-meshheading:14967767-Dementia, pubmed-meshheading:14967767-Female, pubmed-meshheading:14967767-Gait Ataxia, pubmed-meshheading:14967767-Humans, pubmed-meshheading:14967767-Male, pubmed-meshheading:14967767-Memory Disorders, pubmed-meshheading:14967767-Middle Aged, pubmed-meshheading:14967767-Myoclonus, pubmed-meshheading:14967767-Pedigree, pubmed-meshheading:14967767-Penetrance, pubmed-meshheading:14967767-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:14967767-Speech Disorders, pubmed-meshheading:14967767-Spinocerebellar Ataxias, pubmed-meshheading:14967767-TATA-Box Binding Protein, pubmed-meshheading:14967767-Trinucleotide Repeats
pubmed:year
2004
pubmed:articleTitle
Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
pubmed:affiliation
Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
pubmed:publicationType
Journal Article, Case Reports, Research Support, Non-U.S. Gov't